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The Caenorhabditis elegans genome contains a single dystrophin/utrophin orthologue, dys-1. Point mutations in this gene, dys-1(cx35) and
dys-1(cx18), result in truncated proteins. Such mutants offer potentially valuable worm models of human Duchenne muscular dystrophy. We
have used microarrays to examine genes expressed differentially between wild-type C. elegans and dys-1 mutants. We found 106 genes (115
probe sets) to be differentially expressed when the two mutants are compared to wild-type worms, 49 of which have been assigned to six
functional categories. The main categories of regulated genes in C. elegans are genes encoding intracellular signalling, cell–cell communication,
cell-surface, and extracellular matrix proteins; genes in these same categories have been shown by others to be differentially expressed in muscle
biopsies of muscular dystrophy patients. The C. elegans model may serve as a convenient vehicle for future genetic and chemical screens to search
for new drug targets.
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genome, access to mutants, and the utility of microarrays to
monitor the full complement of genes differentially expressed
when wild-type worms and worm models of Duchenne
muscular dystrophy (DMD) are compared. Mutations in the
human dystrophin gene are the cause of DMD, a common
neuromuscular disease affecting 1 in 3500 male births [1]. In
humans, dystrophin is expressed in skeletal, smooth, and
cardiac muscles as well as in the brain [2] and potential
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doi:10.1016/j.ygeno.2006.07.014pharmacological means to up-regulate utrophin, a ubiquitously
expressed autosomal paralogue of dystrophin, in an attempt to
take advantage of the functional redundancy between dystro-
phin and utrophin [3]. In skeletal and cardiac muscle,
dystrophin associates with various proteins to form the
dystrophin-associated protein complex (DAPC), which also
includes syncoilin, dystrobrevin, sarcospan, syntrophins,
sarcoglycans, and dystroglycans [4–6]. Dystrophin is a
structural protein whose function is to increase membrane
stability during repeated cycles of muscular contraction [7]. It
achieves this by stabilizing the sarcolemma during contraction
and relaxation, transmitting force generated in the muscle
sarcomeres to the extracellular matrix [8]. The DAPC has been
involved in signalling via its interactions with growth factor
receptor-bound protein 2 (Grb2), calmodulin, and neuronal
nitric oxide synthase [9]. Further evidence also suggests that
the DAPC may act as a scaffold protein to organize cell
signalling components [9].
Table 1a
Differentially expressed genes in C. elegans dys-1 mutants
Gene ontology classification Up-regulated
genes
Down-regulated
genes
Cell surface and extracellular matrix 8 (19.5%) 2 (3.1%)
Muscle related 0 (0%) 2 (3.1%)
Development and growth 2 (4.9%) 7 (10.8%)
Stress/immune response 2 (4.9%) 3 (4.6%)
Energy metabolism and
mitochondria function
1 (2.4%) 4 (6.2%)
Intracellular signalling and cell–cell
communication
5 (12.2%) 13 (20.0%)
Other 19 (46.3%) 20 (30.8%)
Unknown 4 (9.8%) 14 (21.5%)
Total 41 65
Number of genes in each category is followed by % of differentially expressed
genes.
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counterpart, helping to make the nematode an established animal
model in the study of human disease [9,10]. The C. elegans
homologue for dystrophin is dys-1 [11]. The ethyl methane-
sulfonate-induced cx18 mutation is a G-to-A point mutation
introducing a stop codon at amino acid 2721. The UV-induced
cx35mutation consists of a frameshift caused by a 2-bp deletion
at amino acid 2. Both mutations result in the expression of
truncated DYS-1 protein products in which the C-terminus, a
region essential for the protein's function, is removed [11].
These two mutations in dys-1 do not result in any obvious
muscular degeneration phenotypes but do lead to hyperactivity
and mild hypercontraction of the body wall muscle [11]. The
ability of the human dystrophin cDNA to suppress this
phenotype indicates that a degree of common function has
been conserved between the two proteins [11]. Several other
members of the DAPC have conserved homologues in C.
elegans, such as dystrobrevin, dyb-1 [12], dystroglycans, dgn-1
(T21B6.1), syntrophins, stn-1 [13] and δ/γ-sarcoglycan, sgn-1
(F07H5.2). Like the dys-1 mutant, dyb-1 and stn-1 mutants also
show hyperactivity and a tendency to hypercontract [13,14]. A
combination of a mild mutation in hlh-1, a MyoD-like gene,
with a null mutation in the dys-1 gene produces a time-
dependent muscular degeneration due to the dystrophin-
dependent cellular defect being exacerbated by the mild hlh-1
(cc561) phenotype [15]. Dystrobrevin and dystrophin may have
similar functions, as overexpression of dystrobrevin is able to
delay the onset of myopathy in the C. elegans double mutant
(dys-1; hlh-1) [16].
DNAmicroarray (or chip) technology yields gene expression
profiles utilizing the enormous amounts of sequence data
provided by genome sequencing projects. Microarrays have
been applied effectively to C. elegans. Examples include studies
on genes that influence the life span of the animal [17] as well as
genes that are expressed specifically in mechanoreceptors [18],
are sex regulated [19], and are regulated by overexpression of
the human amyloid peptide Aβ1–42 [20]. Microarray results can
help identify genes regulated in an invertebrate model of human
disease. Here, we examine the genes differentially expressed
between the C. elegans dys-1 mutant and wild-type worms. The
findings are discussed in relation to work on other animal
models of DMD and clinical muscle biopsy studies.
Results
Gene expression analysis
We have analyzed the effects of the dys-1(cx35) and dys-1
(cx18) mutations in the nematode C. elegans using Affymetrix
oligonucleotide microarrays. Total RNA from synchronized
populations of animals on the first day of adulthood was
collected and pooled before being hybridized to Affymetrix
chips. Gene expression profiling showed that 107 genes (115
probe sets) are differentially expressed when the two mutants
are compared with wild-type animals. Of these probe sets, 44
are up-regulated and 71 down-regulated. There are some
similarities between the categories of regulated genes seen indys-1 mutants (Table 1a) and those expressed in human muscle
biopsies from muscular dystrophy patients [21]. In both cases,
“cell surface and extracellular matrix” represent the largest
group of up-regulated genes (19.5% in worms). “Intracellular
signalling and cell–cell communication” represents another
important group of regulated genes in both worm and human
biopsies. However, whereas human biopsies of muscular
dystrophy patients show quite even frequencies between up-
and down-regulation of signalling genes, in dystrophin deficient
worms, signalling genes are in the majority down-regulated
(Table 1a). Far fewer “energy metabolism and mitochondria
function” genes were found regulated in C. elegans compared to
human biopsies (Table 1a, [21]). In addition to functions
ascribed by gene annotation, we have also used GO and KEGG
to classify gene functions (Table 1b). Only 10 of the 107 genes
whose expression was regulated in C. elegans have human
orthologues, so although the functional categories of regulated
genes share similarities with those regulated in human biopsies,
very few orthologous genes are regulated.
In human muscle, proteins contributing to the immune
response are up-regulated. In C. elegans a collagenous lectin,
ficolin (4L35), a major component of the primitive complement
system, is detected as up-regulated along with two C-type
lectins (5P657 and 4E693) known to be involved in the
induction of the primitive C. elegans innate immune response
[22,23]. Particularly striking is the down-regulation of unc-89
coding for a muscle M-line assembly protein (UNC-89) (see
Supplementary Table 2) and the differential regulation of
myosins in both C. elegans and human DMD patients [21] (see
Supplementary Table 4).
Of the 44 probe sets with increased expression, lectins (type
C in particular) feature strongly, with three such genes up-
regulated (Supplementary Table 1). Also up-regulated are a
chloride channel gene (bestrophin); four nuclear protein-
encoding genes, including two nucleoporins (npp-8 and npp-
12); four collagens; one intermediate filament (ifc-2); three
methyltransferase-related transcripts; a ficolin; and a gene (dnj-
16) encoding a heat shock protein, 1 S-adenosylmethionine
synthetase (sams-1), confirmed by 2 probe sets (see supple-
mentary data).
Table 1b
Cat. System Term Count % P value
Up-regulated genes
GO:0042302 Structural constituent
of cuticle
4 9.5% 4.43E-03
GO:0005198 Structural molecule
activity
5 11.9% 7.72E-03
GO:0008168 Methyltransferase activity 3 7.1% 1.63E-02
GO:0016741 Transferase activity,
transferring one-carbon groups
3 7.1% 1.67E-02
KEGG_Pathway Mthionine metabolism
(Caenorhabditis elegans)
2 4.8% 1.29E-02
Down-regulated genes
GO:0030554 Adenyl nucleotide
binding
5 8.2% 8.42E-02
GO:0005524 ATP binding 5 8.2% 8.42E-02
Combined chart of GeneOntology (GO) and KEGG Pathways giving the
frequencies of GO identifiers and pathways found within the selection of
regulated genes and their statistical significance in terms of P-value when
comparing them with the corresponding frequencies in the whole dataset.
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thirteen genes are involved in intracellular signalling and cell–
cell communication, two genes are heat-shock proteins, one is a
DAF protein-encoding gene, one is a sugar transporter (con-
firmed by two probe sets showing consistent levels). Other genes
down-regulated include two neuropeptide-like proteins (nlp-28
and nlp-29C), and an ATPase. Three zinc-finger proteins and
one helicase are also down-regulated, and one putative
mitochondrial protein as well as four kinases and four secreted
or extracellular proteins (one identified as a chorion family
protein) and two chorion family proteins, in total, are all down-
regulated. All these data can be found in Supplementary Table 2.
We also looked at transcripts based on the Affymetrix
decision calls, which correspond to the presence or absence of a
particular mRNA species. As shown in Supplementary Table 3,
124 transcripts are selected this way: 79 transcripts went from
being “absent” in the controls to “present” in the mutants.
Among these genes we again see the involvement of collagens
(col-6, col-7, col-14, col-38, col-49, col-60, col-67Co, col-138,
col-139, col-162), two C-type lectins (5O955 and XH759
showing low expression level in the disease state), as well as a
nucleoporin (npp-8) and several reproduction-related genes
(msp-142, 4H919, 4K799, ssp-11). Other genes were called as
absent in the mutants and present in controls, such as a myosin
heavy chain (let-75), four transport-related genes (two solute
carrier transporters and two rab transcripts), five genes involved
in protein and peptide degradation (two Caenorhabditis
bacteriocins, one chitinase, two meprin/TRAF-like genes),
and one chemoreceptor/gustatory receptor (gur-4).
One aim of this study was to demonstrate the impact of
dystrophin mutations (cx35 and cx18 alleles) on the worm
transcriptome. However, we also explored possible gene
interactions using the online resource supplied by Kim and
colleagues [24]. The method is detailed under Clustering
under Materials and methods. Fig. 1a shows the broad impact
of the dystrophin mutations on the nematode transcriptome
according to the alleles (cx35 and cx18). Using the VxInsightsoftware we plotted differentially expressed probe sets on a
2D map. The 115 regulated probe sets were scattered over 17
referenced mountains, the descriptions of which are given in
Table 2.
Comparing the frequencies of these mountains within the
selection list and the whole array confirms that collagen genes
(mount 22, p value≈0) are highly up-regulated in the
dystrophin mutations. A one-sided Pearson test was performed
on these observed frequencies; corresponding p values are
listed in Table 2. They show that the expression changes of
these clustered transcripts are significant and not likely to be
due to chance alone. Mounts 08 and 28 have a confidence level
of 0.05, in mount 15 it is 0.01, and in mounts 22, 24, 27, and 36
the confidence level was higher than 10−5.
We have also explored the similarity of gene expression
patterns. The dendrogram (Fig. 1b) shows how the selected
transcripts rank according to their similarity based on a
hierarchical clustering using Cluster and TreeView software
[25]. Eight transcripts in the selection are represented by two
probe sets, such as 173398_s_at and 172240_x_at targeting the
F53H2.2 transcript encoding a putative protein. These two
probe sets cluster together in the dendrogram. Similarly,
ZK813.1, encoding a chorion family 2 precursor, is represented
by two probe sets. Others share the same genomic segment, like
B0213.3 (nlp-28) and B0213.4 (nlp-29C) within Chr. V region
3,951,887–3,994,605, corresponding to the cosmid B0213.
Both transcripts encoding neuropeptide-like proteins, ZK813.1
and ZK813.2, within Chr. X region 3,421,666–3,453,572,
which corresponds to the cosmid ZK813, encode a putative
secreted or extracellular protein precursor. All these pairs of
transcripts are tightly clustered. Neuropeptide-like protein
genes nlp-28 and nlp-29C belong to mount 15 corresponding
to three main domains, nuclear, metabolism, and stress response
(Table 2). As with the other selected mount 15 members, they
are down-regulated.
At the top of the dendrogram (Fig. 1b), collagen genes (col-
142, col-81, and col-129) are grouped together with the cuticle
collagen (col-139) belonging to mount 22 annotated as
“Extracellular matrix” and “Collagen.” They show a very
consistent up-regulated expression pattern in which the cx18
allele gives the strongest signal. Mount 22 genes that are down-
regulated feature strongly in the selection, they also form tight
groups with very similar gene expression levels across all
samples. Two mount 27 genes, F29G6.3b (YLP motif containing
protein) and C01F6.6 (solute carrier family 9 regulator 2), which
are up-regulated, cluster with a nuclear hormone receptor
(C01H6.5, nhr-23), which is down-regulated.
Interestingly, the ficolin transcript (Y43C5A.2) clusters with
two C-type lectin family members (5P657 and 4E693),
indicating a particular stress response. The other genes present
in this cluster are a 5-methyltetrahydrofolate–homocysteine
methyltransferase (R03D7.1), a lipid binding protein (lbp-5)
(W02D3.7), an extracellular CUB domain [26]-containing
protein precursor (K06G5.1), and a putative nuclear protein
with a coiled coil-4 domain (F53B2.8).
Genes whose products make up the dystrophin complex in
C. elegans, or are associated with it, were screened for any
Fig. 1. (a) Among the 115 selected transcripts, 74 of those found in the Kim database are plotted using online VxInsight software [24]. Gene expression data obtained
from 553 different experiments are projected onto a 2D space for which the axes give rescaled similarity distances. From all mount 22 transcripts only 1 could be
spotted; therefore mount 22 transcript locations are represented with a dashed triangle, which gives only an indication of the corresponding mountain. (b) Hierarchical
clustering of the selected 115 regulated probe sets. For each selected probe set, quantile normalized expression levels were standardized relative to the corresponding
wild-type mean before running Eisen's Cluster and TreeView software [25]. Probe sets and chips were clustered using the Pearson correlation. Absolute correlation
factors were considered for clustering transcripts (probe sets) so that down-regulated genes (green) may be grouped with other up-regulated genes (red).
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showing a p value below 0.05 and a significant expression level
were found (average expression level above 100, see Supple-
mentary Table 4). The dystrophin transcript (dys-1) was not
detected on any wild-type or mutant microarray.Real-time PCR validation
Three up-regulated and three down-regulated genes were
analyzed by real-time PCR to confirm the differential expres-
sion identified by microarray: C-type lectin (5P657, T09F5.9),
Table 2
Description of the gene clusters (also called mountains/mounts) in which 74 of the 115 transcripts rank
Mount
affiliation
Mount description in terms of
dominant biological functional domains
Kim description p1 frequency (%)
within the selection
list
p0 frequency (%)
within the whole
array list
p value
(one-sided
Pearson test)
Mount 00 Signalling, extracellular matrix, nuclear,
neuronal, and metabolism
– 3.5 10.3 0.9921
Mount 01 Metabolism, nuclear, neuronal Muscle; neuronal; PDZ genes 9.6 8.9 0.3989
Mount 02 Metabolism, nuclear, biosynthesis Germ-line-enriched; oocyte 0.9 6.8 0.9940
Mount 05 Metabolism, nuclear, biosynthesis – 5.2 5.0 0.4626
Mount 06 Neuronal, metabolism, signalling Neuronal genes 3.5 4.0 0.6139
Mount 07 Metabolism, nuclear, signalling Germ-line-enriched; oocyte; meiosis; mitosis 1.7 3.8 0.8771
Mount 08 Metabolism, extracellular matrix,
neuronal
Intestine; Entamoeba histolytica
N-acetylmuraminidase; protease; carboxylesterase;
lipases; antibacterial proteins; UGT
7.0 3.7 0.0343
Mount 09 Signalling, neuronal, extracellular matrix – 1.7 3.7 0.8629
Mount 11 Nuclear, metabolism Germ-line-enriched; oocyte; meiosis; mitosis;
histone H1; retinoblastoma complex
3.5 3.1 0.4028
Mount 15 Nuclear, metabolism, stress response – 3.5 1.1 0.0096
Mount 19 Metabolism, energy metabolism,
extracellular matrix
Amino acid metabolism; lipid metabolism;
cytochrome P450
1.7 0.9 0.1667
Mount 20 Biosynthesis, nuclear, metabolism,
energy metabolism, signalling,
heat shock
Germ-line-enriched; biosynthesis;
protein expression; heat shock
0.9 0.9 0.4965
Mount 22 Extracellular matrix (collagens and
C-type lectin family)
Collagen 9.6 0.7 0
Mount 24 Metabolism, energy metabolism Amino acid metabolism; lipid metabolism;
fatty acid oxidation
5.2 0.6 4.34×10–10
Mount 27 Metabolism, extracellular matrix, muscle Amino acid metabolism; energy generation 5.2 0.5 1.13×10–11
Mount 28 Nuclear, germ-line-enriched – 0.9 0.2 0.0432
Mount 36 Stress response (heat shock) Heat shock 0.9 0.04 3.62×10–6
By screening the gene lists throughout the given annotation a minimal set of qualifying biological domains was extracted for each mountain and listed in decreasing
order of occurrences [24]. Observed proportions of every occurring mountain among both selection and whole-array probe sets are listed with associated p values
obtained from the one-sided Pearson test.
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protease inhibitor (cli-2, K08B4.6), nitrilase (3F11, ZK1058.6),
and nematode-specific RRM-type RNA binding gene (4F59,
F15E6.3). The direction and amplitude of the fold changes
determined by real-time RT-PCR closely match microarray data
for all six genes tested (Fig. 2). These data confirm the validity
of the microarray results.
Discussion
We have used DNA microarrays to investigate differences in
gene expression profiles between wild-type and dys-1 mutant
worm models of the human disease Duchenne muscular
dystrophy [11]. Both dys-1(cx35) and dys-1(cx18) mutants
display body-wall muscle hypercontraction, a phenotype that
can be rescued by a chimeric transgene in which the C-terminus
of dys-1 is replaced by the human dystrophin sequence [11],
demonstrating that the worm and human dystrophin proteins
share functional similarities. In a screen of 100 compounds
tested in a blind assay for their ability to reduce the muscular
degeneration seen in dys-1 mutants [27], the steroid prednisone,
a known drug for palliative treatment of DMD patients, reduced
the number of degenerating cells by 40%.
This microarray study of C. elegans dys-1 mutants shows an
increase in expression for 44 probe sets and a decrease in
expression for 71 probe sets. Table 1a shows the functionalclassification of the up- and down-regulated genes. The largest
groups of regulated genes in C. elegans are intracellular
signalling and cell–cell communication (e.g., neuropeptide-like
proteins) and cell-surface and extracellular matrix (e.g.,
collagens). In human muscle biopsies from muscular dystrophy
patients (DMD and α-sarcoglycan dystrophy) the largest
regulated group of genes is energy metabolism [21]. In humans,
the disease follows a pattern of degeneration and regeneration.
This increase in metabolism, seen in the human patients, may be
caused by an increased demand for energy by the regenerating
muscle. However, in C. elegans striated muscles are devoid of
satellite cells and are unable to regenerate.
Although the loss of dystrophin is clearly the cause of DMD,
this defect triggers several changes that lead to muscle fiber
dysfunction. The inflammation provoked by this damage then
causes further, secondary damage. This can be treated by the
prescription of prednisone, a corticosteroid that reduces the
immune response but is also associated with side effects. It has
been shown that C. elegans relies exclusively on an innate
immune response, as reviewed in [23,28]. The term innate
immunity refers to a number of evolutionarily ancient
mechanisms that serve to defend animals against infection and
has been shown to be induced by infection in C. elegans [29].
By using microarrays G.V. Mallo and colleagues have been able
to demonstrate the up-regulation of many genes known to be
involved in the various arms of the innate immune response
Fig. 2. Real-time RT-PCR validation of microarray data. Real-time RT-PCR was
used to confirm the differential expression of six genes identified by microarray:
C-type lectin (5P657), ficolin (4L35), collagen-129 (col-129), a protease
inhibitor (cli-2), nitrilase (3F11), and nematode-specific RRM-type RNA
binding gene (4F59). Bars represent mean fold change in the dys-1(cx18) and
dys-1(cx35) mutants vs the levels in wild-type C. elegans±SEM (n=3 for
each group). For real-time RT-PCR quantification the expression level of each
gene was normalized to actin expression. Microarray fold changes are shown for
comparison. The direction and amplitude of the fold changes determined by
real-time RT-PCR closely match microarray data for all genes. Changes in
expression in dys-1(cx18) and dys-1(cx35) mutants that are statistically
significant from wild type as assessed by real-time PCR are indicated (one-
way ANOVA and post hoc Tukey's t test, *p<0.05, **p<0.01, ***p<0.001).
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several up-regulated lectins as well as ficolin, which are markers
of the worm's immune response [30]. However, if the immune
response is reduced this may, in part, explain the escape of the
C. elegans dystrophin models from the full devastating effects
of the muscle loss. In Fig. 3, we summarize the key known
components of the dystrophin complex in C. elegans and
highlight genes shown in this study to be regulated.
C. elegans has proved to be an invaluable model for many
human diseases [11]. Its small size, ease of culture, and short life
cycle facilitate the generation and maintenance of genetic
mutant strains. It also benefits from a fully sequenced genome,
with 60% of genes having a human counterpart, and a simple
transparent body plan. The dys-1 mutants have already
demonstrated their usefulness as a model organism by being
used in a screen for drugs that help alleviate the symptoms of
DMD [11,27]. We describe here the analysis of the transcrip-
tomes of these mutants and compare them to those of wild-type
animals using the Affymetrix microarrays. Some of the changesin expression have also been seen in studies using muscle tissue
from DMD patients. The study has highlighted new genes of
interest (Fig. 3) but inherent differences in the molecular
components of the dystrophin complexes of worm and human
counsel caution in the selection of genes to follow up for further
study. However, we consider that the mutants dys-1(cx-35) and
dys-1(cx-18) highlighted here, as well as the unc-89 mutant or
col mutants, merit further functional analysis using the C.
elegans genetic toolkit. Thus, C. elegans offers a useful
platform for the study of aspects of muscular dystrophy and
in the future may help identify new routes to therapy.Materials and methods
RNA preparation from wild-type and dys-1 worms
N2 and dys-1 animals were synchronized by bleaching and grown to adults
at 21°C for 65 h. Total RNA was extracted using the Trizol procedure
(Invitrogen No. 15596-026) and further purified using the RNeasy mini kit
(Qiagen No. 74104) according to the manufacturers' protocols.
Microarray experiments
Each sample was made up of a pool of three replicate RNA samples
collected at different times (wild type (wt), M4, M11, M12; cx35, M14, M15,
M16; cx18, M62, M63, M64). We found that pooled samples gave us a lower
degree of variance, as has been suggested mathematically [31]. We did not
carry out technical replicates for each sample as the variance between chips is
very low in our hands (<2%). Five micrograms of total RNA was used to
generate biotin-labeled cRNA probes and 15 μg of fragmented cRNAwas used
in 300 μl of hybridization cocktail, hybridized to a high-density oligonucleotide
C. elegans genome array (Affymetrix). All the procedures and hybridizations
were performed in triplicate according to the GeneChip Expression Technical
Manual (Affymetrix).
Following hybridization, the arrays were processed using a GeneChip
Fluidics Station 400 according to recommended protocols (EukGE-WS2v4,
Affymetrix) for double-staining and posthybridization washes. Fluorescent
images were captured using GeneArray Scanner 2500 (Affymetrix).
Data analysis was performed using Bioconductor software and R statistics.
The normalization was carried out at the probe level on background-adjusted
intensities.
Microarray signal data sets were first quantile normalized [32] to make their
probe intensity distribution the same across all chips to aid comparison. The
normalization method that was implemented does not depend on a baseline
array. Instead all arrays were used to compute an average reference quantile data
set that gives the new data distribution of each array. A log2 transformation was
then applied to the normalized data, which were found to stabilize the variance
between probes. A one-way analysis of variance (ANOVA) modeling was fitted
to the log-transformed data, in which treatments correspond to the sample types,
wt, cx35, and cx18. The linear model for each probe-set expression level is
given as
yij ¼ lþ ai þ eijði ¼ 1; N ; 3; j ¼ 1; ; ; ; ; 3Þ;
where μ is the overall mean for a single probe set, αi the effect of treatment I,
and εij the random error associated with the jth observation for the ith treatment;
p values were then obtained by performing an F test and computing two
contrasts, cx35 vs wt and cx18 vs wt.
A fold change between each allele (cx35, cx18) and wild type was computed
considering the average ratio of normalized perfect match data. Only transcripts
showing a significant expression change and a mean expression level above a
threshold of 100 were kept for further analysis. A gene expression change was
considered significant if both contrasts cx35 vs wt and cx18 vs wt gave p values
below 0.01, corresponding changes were in the same direction (both up or both
down), and the changes were more than 50%. We also screened members of the
Fig. 3. Most differentially expressed genes in dys-1 C. elegans mutants. Red symbols correspond to up-regulated genes, green to those down-regulated. The
selection was based on p values lower than 0.01 and the combined cx35 and cx18 vs wild-type comparisons showing at least 50% change in the same
direction.
648 P.R. Towers et al. / Genomics 88 (2006) 642–649dystrophin complex and related genes even if they failed to meet the selection
criteria because of the interest in understanding DMD pathology (Supplemen-
tary Table 4).
Clustering
We used the supplementary data and online scatter-plot tool (cf. URLs http://
cmgm.stanford.edu/∼kimlab/topomap/c._elegans_topomap.htm and http://
workhorse.stanford.edu/cgi-bin/plot/plotcoordinates.pl) to cluster our selected
regulated genes on a 2D map (Fig. 1a). According to Kim et al. [24] this map,
based on their database and the VxInsight software, represents 94% of the whole
genome. To assess the statistical significance of the mountains identified in our
experiment, we computed p values based on the comparison of mountain
frequencies inside the selection list, on one hand, and the whole array list, on the
other hand. A one-sided Pearson test was performed on these observed
frequencies (Table 2).
A hierarchical clustering was performed on the data limited to the 115 probe
sets selection using Cluster and TreeView software [25]. Prior to the Cluster
analysis, quantile normalized data were standardized by subtracting from each
gene expression level the corresponding wild-type mean and dividing the result
by the pooled standard error. Probe sets and chips were clustered using the
Pearson correlation. Absolute correlation factors were considered for clustering
transcripts (probe sets) so that down-regulated may be grouped with other up-
regulated transcripts.
Real-time PCR experiments
Real-time PCR analysis was performed with the double-stranded DNA
binding dye SYBR Green I using the ABI Prism 7000 sequence detection
system (Applied Biosystems). Three up-regulated and three down-regulated
genes were selected for real-time PCR analysis: C-type lectin (5P657, T09F5.9),
ficolin (4L35, Y43C5A.2), collagen-129 (col-129, M18.1), protease inhibitor
(cli-2, K08B4.6), nitrilase (3F11, ZK1058.6), and nematode-specific RRM-type
RNA binding gene (4F59, F15E6.3). Actins (act-1, act-2, act-3, act-4, and act-5;
T04C12.6, T04C12.5, T04C12.4, M03F4.2, and T25C8.2, respectively) were
identified as suitable housekeeping genes for normalization because our
microarray data had demonstrated them to have constant expression in wild-
type and cx18 and cx35 dys-1 mutant C. elegans. Primers were designed using
Primer Express (Applied Biosystems). All primer pairs span an intron. Forward
and reverse primer sequences in the 5′–3′ direction for each gene are as follows:
col-129, CGTCAATGATGTCAACAATTACTATGAT and TTGGTGCCA-
GACGGTATTAGC; 5P657, GCTTGGGCAGATTCGACTAAATT andTCCCTGCTGTCTCAACAAATACA; 4L35, GGACTTGGGTGTAATGTT-
TATTTACAAG and TGTCAATGTGTTTGAGCTCGAA; 3F11, CTCTCTAC-
CATGAGGACTATTGCATT and GAAGTGGGTGATCCAAGGGATA; cli-2,
TGGAGCAGCTTGGAATTCG and CCGGCAACAACTTGAACTTGA; 4F59,
TTCTGCTTGGCCTTATTGCAA and CCACGTTGAAAACCTCCGTTTA;
and for conserved regions in act-1, act-2, act-3, act-4, and act-5, TGCTGATCG-
TATGCAGAAGGA and CCGATCCAGACGGAGTACTTG.
cDNA synthesis
The pooled total RNA samples used for microarray analysis (wt, cx35, and
cx18, n=3 for each group) were used for cDNA synthesis. Two micrograms of
each RNA sample was treated with DNase I (amplification grade; Invitrogen) in
a reaction volume of 10 μl. Five microliters of the DNase I-treated RNA was
used for reverse transcription in a 20-μl reaction volume using the Superscript III
First-Strand Synthesis SuperMix kit with oligo(dT)20 primers (Invitrogen)
according to the manufacturer's instructions. Reverse transcriptase-negative and
no-template control reactions were run in parallel. Standard cDNA to be used for
the construction of relative standard curves for quantification were prepared in
the same way as experimental samples using a pool of RNA consisting of a 2:1:1
ratio of pooled wt, cx35, and cx18 RNA samples, respectively. A seven-point
standard curve was constructed by performing a 1 in 2 serial dilution of standard
cDNA in nuclease-free water. Experimental cDNA samples were diluted 1 in 4
with nuclease-free water so that they would amplify within the range of the
standard curve.
Real-time PCR
All PCRs were run in triplicate to determine average cycle at threshold (Ct)
values for each sample. Real-time PCRs were run in a 25-μl volume containing
1× SYBR Green Master Mix (Applied Biosystems), 300 nM forward and
reverse primers (Sigma Genosys), distilled water, and 2 μl template cDNAwith
the following cycling parameters: hold at 50°C for 2 min and 95°C for 10 min
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. A dissociation
protocol was performed at the end of each experiment and melting curves were
inspected for nonspecific amplification. The PCR products were also analyzed
by agarose gel electrophoresis and were the predicted size of the cDNA
amplicon. Real-time PCR data were analyzed using ABI Prism SDS software.
Linear regression of the log of relative standard cDNA input quantity against
Ct values gave standard curves with R
2 values above 0.98 for all genes: actins,
y=−3.5667x+19.061; col-129, y=−3.8253x+23.271; 3F11, y=−4.0961x+
30.193; 4F59, y=−4.1127x+28.975; 4L35, y=−3.8316x+26.064; cli-2, y=
649P.R. Towers et al. / Genomics 88 (2006) 642–649−3.8573x+22.953; 5P657, y=−4.0744x+26.667. Average Ct values of
experimental samples were converted into relative quantities using the
following formula: quantity=10((Ct − intercept)/slope). The relative quantity of
each gene was normalized to actin and calibrated to the average normalized
expression in wt samples to calculate fold change. One-way ANOVA and post
hoc Tukey's t test were used to calculate statistical significance.
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